Legal Representation
Attorney
Mainak H. Mehta
USPTO Deadlines
Next Deadline
534 days remaining
Section 71 Renewal Due (Principal Register 66a) (Based on registration date 20170606)
Due Date
June 06, 2027
Grace Period Ends
December 06, 2027
Application History
42 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 7, 2025 | RNWL | P | INTERNATIONAL REGISTRATION RENEWED | Loading... |
| Feb 13, 2024 | NA75 | E | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | Loading... |
| Feb 13, 2024 | C75A | O | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | Loading... |
| Feb 12, 2024 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jun 6, 2023 | ES75 | I | TEAS SECTION 71 & 15 RECEIVED | Loading... |
| Jun 6, 2022 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| Oct 28, 2017 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Sep 14, 2017 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Sep 14, 2017 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Sep 6, 2017 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jun 6, 2017 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 21, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 21, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 17, 2017 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Mar 10, 2017 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Mar 1, 2017 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Mar 1, 2017 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Mar 1, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 13, 2017 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 10, 2017 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Feb 1, 2017 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 1, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 1, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 1, 2017 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 1, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 16, 2016 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Sep 1, 2016 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Sep 1, 2016 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Sep 1, 2016 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Aug 16, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 16, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 16, 2016 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 10, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 27, 2016 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Feb 10, 2016 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Feb 10, 2016 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Feb 10, 2016 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Feb 9, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 9, 2016 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 3, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 3, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 30, 2016 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Chemicals used in industry, science, photography; chemicals used in agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticides; chemical reagents and reactants in this class for non-medical purposes; enzymes for industrial purposes, namely, for use in the biotechnology industry; nucleic acid sequences, other than medical and veterinary purposes; nucleic recombinant acids; acids, namely, inorganic acids; organic acids for use in the biotechnology industry; DNA polymerase, other than medical and veterinary purposes; chemicals used in food processing and screening; chemicals used in environmental monitoring
Class 005
Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens for medical and veterinary purposes; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes; medical kits in this class consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; diagnostic reagents for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
Class 010
Surgical, medical and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; diagnostic testing apparatus and instruments for medical purposes, namely, for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; point of care medical devices for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; medical screening apparatus in this class for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy
Additional Information
Pseudo Mark
PLEX PRIME
Classification
International Classes
001
005
010